Regulatory concerns regarding AIDS vaccine development.
D000163:Acquired Immunodeficiency Syndrome; D032761:Animal Experimentation; D000827:Animal Welfare; D000818:Animals; D035061:Control Groups; D064420:Drug-Related Side Effects and Adverse Reactions; D035082:Federal Government; D006076:Government; D033161:Government Regulation; D006679:HIV Seropositivity; D006805:Human Experimentation; D006801:Humans; D007114:Immunization; D007391:International Cooperation; D038622:Internationality; D005791:Patient Care; D018579:Patient Selection; D004364:Pharmaceutical Preparations; D011897:Random Allocation; D012107:Research Design; D035842:Research Subjects; D012306:Risk; D018570:Risk Assessment; D012926:Social Control, Formal; D014481:United States
Biomedical and Behavioral Research; Health Care and Public Health; Legal Approach